Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy-Reference-Cited by-同舟云学术

Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy

Published:2021-08 Issue: Volume:156 Page:105410
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Sharma Shaunik,Carlson Steven,Gregory-Flores Adriana,Hinojo-Perez Andy,Olson Ashley,Thippeswamy Thimmasettappa

Funder

National Institutes of Health

Foundation for the National Institutes of Health

National Institute of Neurological Disorders and Stroke

Publisher

Elsevier BV

Subject

Neurology

Reference59 articles.

1. NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox;Anrather;Biol. Chem.,2006

2. Postsynaptic density protein 95-regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat models;Ba;Drug Des. Devel. Ther.,2014

3. Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors;Baselga;Clin. Cancer Res.,2010

4. N (w) -propyl-L-arginine (L-NPA) reduces status epilepticus and early epileptogenic events in a mouse model of epilepsy: behavioural, EEG and immunohistochemical analyses;Beamer;Eur. J. Neurosci.,2012

5. Pattern of use and long-term safety of tyrosine kinase inhibitors: a decade of real-world management of chronic Myeloid Leukemia;Bettiol;Clin. Drug Investig.,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Immune system mechanisms impacting the onset of epilepsy and spontaneous seizures;Frontiers in Molecular Neuroscience;2024-09-10

2. Bioinformatics analysis of potential pathogenesis and risk genes of neuroinflammation-promoted brain injury in intracerebral hemorrhage;Brain Hemorrhages;2024-07

3. Neuroprotective effects of naltrexone in a mouse model of post-traumatic seizures;Scientific Reports;2024-06-12

4. Dual Drug Repurposing: The Example of Saracatinib;International Journal of Molecular Sciences;2024-04-22

5. Role of non-receptor tyrosine kinases in epilepsy: significance and potential as therapeutic targets;Expert Opinion on Therapeutic Targets;2024-04-02